BioMarin to Participate in Four Upcoming Virtual Investor Conferences
- J.P. Morgan U.S. All Stars Conference on September 16 at 11:00am ET/4:00BST
- Cantor Virtual Global Healthcare Conference on September 16 at 2:40pm ET
- BofA Global Healthcare Conference 2020 on September 17 at 11:45am ET/4:45pm BST
- Morgan Stanley 18th Annual Global Healthcare Conference on September 17 at 2:00pm ET
SAN RAFAEL, Calif., Sept. 15, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in four upcoming virtual conferences. An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.
Contacts: |
|
Investors |
Media |
Traci McCarty |
Debra Charlesworth |
BioMarin Pharmaceutical Inc. |
BioMarin Pharmaceutical Inc. |
(415) 455-7558 |
(415) 455-7451 |
SOURCE BioMarin Pharmaceutical Inc.
![](https://rt.prnewswire.com/rt.gif?NewsItemId=SF21710&Transmission_Id=202009150830PR_NEWS_USPR_____SF21710&DateId=20200915)
Share this article